Lung cancer clinical trials
3,236 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all lung cancer studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting lung cancer studies. A study counts once in each state where it has a site.
- Texas413
- California400
- New York373
- Florida313
- Massachusetts246
- Ohio246
- Pennsylvania239
- Virginia232
- Tennessee227
- Maryland212
- Michigan210
- Illinois209
Also in China (1,052), France (323), Spain (252), Italy (247), Canada (206), Australia (181), South Korea (177), United Kingdom (175).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 135
- Phase 1336
- Phase 1 / Phase 2309
- Phase 2652
- Phase 2 / Phase 347
- Phase 3213
- Phase 444
- No phase (devices, programs)630
- Observational734
There are more than 3,000 recruiting studies, so the location and study-type counts cover the 3,000 most relevant.
Recently updated studies
Recruiting lung cancer studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingPhase 2NCT07447817
Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias
Ages 18 Years and over · Westwood, Kansas · New York, New York +1 more · John Mascarenhas
- RecruitingPhase 3NCT06422143
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Ages 18 Years and over · Little Rock, Arkansas · Burbank, California +186 more · Merck Sharp & Dohme LLC
- RecruitingPhase 3NCT04267848
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ages 18 Years and over · Anchorage, Alaska · Fairbanks, Alaska +749 more · National Cancer Institute (NCI)
- RecruitingPhase 3NCT06875310
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Ages 18 Years and over · Birmingham, Alabama · Springdale, Arkansas +278 more · Mirati Therapeutics Inc.
- RecruitingPhase 1NCT07782359
Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
Ages 18 Years and over · Chicago, Illinois · University of Chicago
- RecruitingPhase 1NCT07705035
DBC-664 in Adult Patients With Solid Tumors
Ages 18 Years and over · Denver, Colorado · Grand Rapids, Michigan +5 more · Duboce Biopharmaceuticals, Inc.
- RecruitingPhase 2NCT07415031
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Ages 18 Years and over · Phoenix, Arizona · Bellflower, California +90 more · Mirati Therapeutics Inc.
- RecruitingPhase 2NCT07155174
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Ages 18 Years and over · New Haven, Connecticut · Gainesville, Florida +58 more · AbbVie
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.